Other OTC exchange. Sector: Healthcare. Industry: Medical Instruments & Supplies. Location United States, Gardner.

Precision Optics Corporation, Inc. [PEYEUnited States

2.02USD0.03 (-1.49%)

• At close Fri Oct 07 2022

32,604,000 USD
MARKET CAP
.
PE
0.368
BETA (5y)
-0.076
EPS

profit

242%

for 5 years

profit

76%

for 3 years

profit

13%

for 2 years

profit

9%

for 1 year

profit

-8%

for this year

About Precision Optics Corporation, Inc.

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies, which are designed for industrial and military use. The company markets its products to original equipment manufacturers through medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.

Precision Optics Corporation designs and manufactures micro optics and optical assemblies for innovative applications, like minimally invasive surgery.

Precision Optics Corporation, Inc.
https://www.poci.com
© 2022 avazzy.com. All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.